ADC BioMedical

ADC BioMedical is a Canadian life science and medical-cannabis company that appears to operate as a wholly owned subsidiary of CanaQuest Medical Corp. The company holds a Health Canada licence related to the sale, import, and export of medical cannabis and cannabinoid products, and has been positioned as the commercialization vehicle for CanaQuest-originated formulations such as Mentanine and Mentabinol. Publicly available information suggests its business centers on regulated distribution and commercialization of cannabinoid-based health products rather than a broad traditional drug-development pipeline. The company is active in Canada and is associated with cannabis-derived formulations targeting mental health and inflammation-related conditions.